AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 283: R205-R217, 2002. First published April 4, 2002; doi:10.1152/ajpregu.00122.2002
0363-6119/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/1/R205    most recent
00122.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Auman, J. T.
Right arrow Articles by Slotkin, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Auman, J. T.
Right arrow Articles by Slotkin, T. A.
Vol. 283, Issue 1, R205-R217, July 2002

Are developing beta -adrenoceptors able to desensitize? Acute and chronic effects of beta -agonists in neonatal heart and liver

J. T. Auman, F. J. Seidler, C. A. Tate, and T. A. Slotkin

Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710

During fetal and neonatal development, beta -adrenergic receptors (beta -ARs) appear to be resistant to desensitization by beta -agonist drugs. To determine the mechanisms underlying the regulatory differences between adults and neonates, we administered isoproterenol, a mixed beta 1/beta 2-AR agonist, and terbutaline, a beta 2-selective agonist. Effects were examined in the ensuing 4 h after a single injection, or after the last of four daily injections. We prepared cell membranes from heart (predominantly beta 1-ARs) and liver (predominantly beta 2-ARs) and assessed signal transduction in the adenylyl cyclase (AC) pathway. In the first few hours after a single administration of isoproterenol to adult rats, cardiac beta -ARs showed activation of G proteins (elevated AC response to forskolin) and desensitization of beta -AR-mediated responses; after the fourth injection, heterologous desensitization emerged, characterized by a loss of signaling mediated either through beta -ARs or glucagon receptors. Terbutaline evoked an increase in the forskolin response but no desensitization of receptor-mediated responses. When we gave the same treatments to neonatal rats, we observed cardiac G protein activation, but there was neither homologous nor heterologous desensitization of beta -ARs or glucagon receptors. In the adult liver, isoproterenol and terbutaline both failed to evoke desensitization, regardless of whether the drugs were given once or for 4 days. In neonates, however, acute or chronic treatment elicited homologous desensitization of beta -AR-mediated AC signaling, while sensitizing the response to glucagon. These results show that neonatal beta -ARs are inherently capable of desensitization in some, but not all, cell types; cellular responses can be maintained through heterologous sensitization of signaling proteins downstream from the receptor. Differences from adult patterns of response are highly tissue selective and are likely to depend on ontogenetic differences in subtypes of beta -ARs and AC.

adenylyl cyclase; adenosine 3',5'-cyclic monophosphate; development; isoproterenol; terbutaline


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
G. S. Lynch and J. G. Ryall
Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease
Physiol Rev, April 1, 2008; 88(2): 729 - 767.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. Beitzel, M. N. Sillence, and G. S. Lynch
beta-Adrenoceptor signaling in regenerating skeletal muscle after beta-agonist administration
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E932 - E940.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Y.-T. Tseng, N. Yano, A. Rojan, J. P. Stabila, B. G. McGonnigal, V. Ianus, R. Wadhawan, and J. F. Padbury
Ontogeny of phosphoinositide 3-kinase signaling in developing heart: effect of acute {beta}-adrenergic stimulation
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1834 - H1842.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. L. Peffer, X. Lin, and J. Odle
Hepatic {beta}-oxidation and carnitine palmitoyltransferase I in neonatal pigs after dietary treatments of clofibric acid, isoproterenol, and medium-chain triglycerides
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1518 - R1524.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
F. Beitzel, P. Gregorevic, J. G. Ryall, D. R. Plant, M. N. Sillence, and G. S. Lynch
{beta}2-Adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury
J Appl Physiol, April 1, 2004; 96(4): 1385 - 1392.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. T. Auman, F. J. Seidler, and T. A. Slotkin
beta -Adrenoceptor control of G protein function in the neonate: determinant of desensitization or sensitization
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1236 - R1244.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online